Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Amneal Pharmaceuticals Inc 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 USA

www.amneal.com P: 908-947-3120 F: 908-947-3146

Description:

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,700,819
Enterprise Value, $K 4,283,579
Shares Outstanding, K 307,007
Annual Sales, $ 2,394 M
Annual Net Income, $ -83,990 K
Last Quarter Sales, $ 616,980 K
Last Quarter Net Income, $ -98,650 K
EBIT, $ 235,170 K
EBITDA, $ 472,750 K
60-Month Beta 1.33
% of Insider Shareholders 17.46%
% of Institutional Shareholders 31.82%
Float, K 253,404
% Float 82.54%
Short Volume Ratio 0.43

Growth:

1-Year Return 307.35%
3-Year Return -2.46%
5-Year Return -55.43%
5-Year Revenue Growth 43.93%
5-Year Earnings Growth -42.11%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.14 on 03/01/24
Latest Earnings Date 05/03/24
Earnings Per Share ttm 0.55
EPS Growth vs. Prev Qtr -29.41%
EPS Growth vs. Prev Year -42.86%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AMRX Ratios

Ratio
Price/Earnings ttm 10.04
Price/Earnings forward 11.04
Price/Earnings to Growth N/A
Return-on-Equity % 126.04%
Return-on-Assets % 4.00%
Profit Margin % -3.51%
Debt/Equity 131.96
Price/Sales 0.71
Price/Cash Flow 4.09
Price/Book 84.57
Book Value/Share 0.07
Interest Coverage -0.81
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar